Cargando…
P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431167/ http://dx.doi.org/10.1097/01.HS9.0000971636.16625.73 |
| _version_ | 1785091136967147520 |
|---|---|
| author | Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin |
| author_facet | Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin |
| author_sort | Zhang, Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431167 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311672023-08-17 P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431167/ http://dx.doi.org/10.1097/01.HS9.0000971636.16625.73 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, Yan Chen, Chao Zhao, Danqing Zhuang, Zhe Wei, Chong Wang, Wei Zhang, Wei Zhou, Dao-Bin P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title | P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title_full | P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title_fullStr | P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title_full_unstemmed | P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title_short | P1185: A PROSPECTIVE SINGLE-CENTER PHASE 2 STUDY OF ZANUBRUTINIB PLUS R-CHOP IN TREAT-NAÏVE INTRAVASCULAR LARGE B CELL LYMPHOMA |
| title_sort | p1185: a prospective single-center phase 2 study of zanubrutinib plus r-chop in treat-naïve intravascular large b cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431167/ http://dx.doi.org/10.1097/01.HS9.0000971636.16625.73 |
| work_keys_str_mv | AT zhangyan p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT chenchao p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT zhaodanqing p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT zhuangzhe p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT weichong p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT wangwei p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT zhangwei p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma AT zhoudaobin p1185aprospectivesinglecenterphase2studyofzanubrutinibplusrchopintreatnaiveintravascularlargebcelllymphoma |